Revolutionary AI tool forecasts kidney injury signs with high accuracy in intensive care

A machine-learning (ML) algorithm for predicting oliguria.

How payer-participating trials could help transform clinical research on FDA-approved drugs

Earlier this year, Food and Drug Administration Commissioner Robert M. Califf proposed something radical: that private health care insurance companies (payers) should participate in clinical

October 6, 2023

FDA approves Roche’s injectable version of blockbuster multiple sclerosis drug

Swiss pharma giant Roche won approval from the Food and Drug Administration on Friday for an injectable version of its blockbuster multiple sclerosis therapy Ocrevus,

September 13, 2024

M&A: Viome Acquires Naring Health

What You Should Know: Viome Life Sciences, a longevity company committed to translating scientific advancements into actionable and individualized health solutions, today announced the acquisition

November 2, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.